KASTELEIN JOHANNES JACOB PIETER (Chief Scientific Officer) received a stock award from NEWAMSTERDAM PHARMA CO N.V.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/28/2025ACC: 0000950170-25-046947
DirectorOfficer· Chief Scientific Officer
Since Mar 2026
+64.78K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
110.26K acquired · 45.48K disposed
Non-Derivative Transactions2
Ordinary Shares
Indirect
Shares
+19.30K
Price / share
—
Trade value
—
% of position
12.9%
3/26/2025
150K→169.30K
Ordinary Shares
Direct
Shares
+45.48K
Price / share
—
Trade value
—
% of position
133.8%
3/26/2025
34K→79.48K
Total
Net shares
+64.78K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Indirect | 3/26/2025 | A · Award | +19.30K | — | — | 12.9% | 150K | 169.30K |
| Ordinary Shares Direct | 3/26/2025 | M · Option Exercise | +45.48K | — | — | 133.8% | 34K | 79.48K |
| Total | +64.78K | $0.00 | ||||||
Derivative Transactions2
Restricted Stock Unit
Direct
Converts to
Ordinary Shares
45.48K shares
Shares
+45.48K
Strike price
Held after
45.48K
Exercisable
—
3/26/2025
Restricted Stock Unit
Direct
Converts to
Ordinary Shares
45.48K shares
Shares
−45.48K
Strike price
Held after
0.00
Exercisable
—
3/26/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Ordinary Shares45.48K shares | 3/26/2025 | A · Award | +45.48K | — | 45.48K | |
| Restricted Stock Unit Direct | Ordinary Shares45.48K shares | 3/26/2025 | M · Option Exercise | −45.48K | — | 0.00 |